open access

Vol 51, No 4 (2020)
Untitled
Published online: 2020-12-01
Submitted: 2020-05-04
Get Citation

Myeloid-derived suppressor cells level and expression in de novo acute myeloid leukemia

Sarah M. Nawar, Hala K. Sultan, Ahmed M. Bedewy, Amel A. ElNaggar, Irene L. Mikhael
DOI: 10.2478/ahp-2020-0042
·
Acta Haematol Pol 2020;51(4):245-252.

open access

Vol 51, No 4 (2020)
Untitled
Published online: 2020-12-01
Submitted: 2020-05-04

Abstract

Background

Acute myeloid leukemia (AML) is the most common acute leukemia occurring in adults. It is an aggressive myeloid neoplasm with maturation arrest of myelopoiesis, leading to an accumulation of myeloblasts in the bone marrow and peripheral blood.

Objective

To evaluate alterations in myeloid-derived suppressor cells level and gene expression in patients with de novo acute myeloid leukemia concerning disease characteristics and response to induction chemotherapy.

Patients and methods

The study was performed on 50 AML patients and 50 healthy controls. Detection of myeloid-derived suppressor cells (MDSCs) in peripheral blood was performed by mononuclear separation and flow cytometry. gene expression was performed by RNA extraction, reverse transcription, and real-time PCR at Hematology Department Medical Research Institute, Alexandria University.

Results

We have demonstrated that AML patients had both increased presence of MDSCs in peripheral blood as well as MUC1 overexpression in comparison to normal controls. MDSCs showed a significant correlation regarding response to induction chemotherapy on day 28. While MDSCs and not MUC1 are associated with inferior response to induction chemotherapy on day 28.

Conclusion

The current data suggested that AML patients exhibit an increased presence of MDSCs as well as gene overexpression in comparison with normal controls. While MDSCs showed a significant correlation regarding response to induction chemotherapy on day 28, MDSCs and not MUC1 are associated with inferior response to induction chemotherapy on the same day.

Abstract

Background

Acute myeloid leukemia (AML) is the most common acute leukemia occurring in adults. It is an aggressive myeloid neoplasm with maturation arrest of myelopoiesis, leading to an accumulation of myeloblasts in the bone marrow and peripheral blood.

Objective

To evaluate alterations in myeloid-derived suppressor cells level and gene expression in patients with de novo acute myeloid leukemia concerning disease characteristics and response to induction chemotherapy.

Patients and methods

The study was performed on 50 AML patients and 50 healthy controls. Detection of myeloid-derived suppressor cells (MDSCs) in peripheral blood was performed by mononuclear separation and flow cytometry. gene expression was performed by RNA extraction, reverse transcription, and real-time PCR at Hematology Department Medical Research Institute, Alexandria University.

Results

We have demonstrated that AML patients had both increased presence of MDSCs in peripheral blood as well as MUC1 overexpression in comparison to normal controls. MDSCs showed a significant correlation regarding response to induction chemotherapy on day 28. While MDSCs and not MUC1 are associated with inferior response to induction chemotherapy on day 28.

Conclusion

The current data suggested that AML patients exhibit an increased presence of MDSCs as well as gene overexpression in comparison with normal controls. While MDSCs showed a significant correlation regarding response to induction chemotherapy on day 28, MDSCs and not MUC1 are associated with inferior response to induction chemotherapy on the same day.

Get Citation

Keywords

acute myeloid leukemia; induction response; Array; myeloid-derived suppressor cells

About this article
Title

Myeloid-derived suppressor cells level and expression in de novo acute myeloid leukemia

Journal

Acta Haematologica Polonica

Issue

Vol 51, No 4 (2020)

Pages

245-252

Published online

2020-12-01

DOI

10.2478/ahp-2020-0042

Bibliographic record

Acta Haematol Pol 2020;51(4):245-252.

Keywords

acute myeloid leukemia
induction response
Array
myeloid-derived suppressor cells

Authors

Sarah M. Nawar
Hala K. Sultan
Ahmed M. Bedewy
Amel A. ElNaggar
Irene L. Mikhael

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl